Health Technology Assessments by the National Institute for Health and Clinical Excellence - A Qualitative Study

The National Institute for Health and Clinical Excellence (NICE) has been regarded as a role model for the implementation of cost-effectiveness analysis (CEA), and is being closely watched by health care policy makers across the globe. This book examines Britain's highly acclaimed approach to CEA and its international potential. It dissects the robustness of the agency's technology appraisal processes as NICE evaluates innovative methods for diagnosis and intervention. Coverage provides a step-by-step explanation of the NICE appraisal process and examines its successes and limitations.


Michael Schlander is founder and chairman of the independent Institute for Innovation & Valuation in Health Care (InnoValHC), a non-profit, non-partisan scientific organization dedicated to research related to the utilization, effectiveness, efficiency, and quality of health care, with particular emphasis on novel approaches of service provision. He teaches health economics and innovation management at the University of Duisburg-Essen (Faculty of Medicine, since 2005) and at the University of Applied Economic Sciences Ludwigshafen, Germany (since 2002). Prior to his university appointment, he spent fifteen years in senior positions with international pharmaceutical companies in Germany, Belgium, and the United States, and six years in experimental brain research and clinical neurology at German universities.